Glycemic variability elevates risk of vascular events, death

May 16, 2014
Glycemic variability elevates risk of vascular events, death

(HealthDay)—Visit-to-visit variability (VVV) in glycated hemoglobin (HbA1c) and fasting glucose correlate with major adverse outcomes for patients with type 2 diabetes, according to a study published online May 8 in Diabetes Care.

Yoichiro Hirakawa, M.D., from the University of Sydney in Australia, and colleagues examined the impact of VVV in HbA1c and fasting glucose on outcomes among patients with type 2 who were participating in the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. The standard deviation of five measurements of HbA1c and glucose taken three to 24 months after randomization was used to define VVV among 4,399 patients in the intensive glucose treatment group.

The researchers found that an increase in VVV of HbA1c in the intensive group correlated with an increased risk of vascular events (P = 0.01) and with mortality (P < 0.001). After multivariable adjustment, the hazard ratios for the highest versus the lowest tenth were 1.64 and 3.31 for vascular events and mortality, respectively. VVV of correlated with increased risk of vascular events (hazard ratio, 2.70; P < 0.001). There was a positive association for HbA1c variability with the risk of macrovascular events (P = 0.02 for trend), while correlations were seen for glucose variability with macro- and microvascular events (P = 0.005 and 0.001 for trend, respectively). The results were broadly consistent in sensitivity analyses using other indices and for patients in the standard glucose treatment group.

"Consistency of glycemic control is important to reduce the risks of vascular events and death in ," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Servier International, which funded the ADVANCE trial.

Explore further: Measures of glucose and its variability are inter-related

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Measures of glucose and its variability are inter-related

September 11, 2013
(HealthDay)—Hemoglobin A1c (HbA1c) and glycated albumin (GA) are inter-related and correlate with retinopathy and nephropathy, while only HbA1c correlates with cardiovascular disease, according to a study published online ...

Blood glucose levels set for achieving HbA1c targets

April 11, 2014
(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according to research published ...

Intensive insulin rx lowers glycemic variability in early DM

April 15, 2014
(HealthDay)—Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue ...

Fasting plasma glucose beats HbA1c for diabetes screening

January 17, 2013
(HealthDay)—For patients without diabetes undergoing coronary angiography (CAG), fasting plasma glucose (FPG) performs better in diabetes screening than glycated hemoglobin (HbA1c), according to a study published online ...

Study indicates the potential of new tests in long-term diabetes complications

January 14, 2014
Monitoring glucose levels is imperative for diabetes patients, but for some the standard Hemoglobin A1c (HbA1c) test is not valid. Researchers from Johns Hopkins University, the University of Wisconsin, and the University ...

Change in guidelines for Type 2 diabetes screening may lead to under-diagnosis in children

February 11, 2014
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.

Recommended for you

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.